Company: MDCXW
Filing Date: 2025-12-30
Form Type: S-3
Source: 0001062993-25-017488
Chunk: 22

Company: Medicus Pharma Ltd.
Filing Date: 2025-12-30
Form: S-3
Chunk 22
---
 prior 12-calendar-month period that ends on and includes the date of this prospectus supplement. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell, pursuant to the registration statement of which this prospectus supplement forms a part, securities with a value exceeding one-third of the aggregate market value of our outstanding common shares held by non-affiliates in any 12-month period, so long as the aggregate market value of our outstanding common shares held by non-affiliates remains below $75.0 million.

Investing in our common shares involves a high degree of risk. See "Risk Factors" beginning on page S-12 of this prospectus supplement and under similar headings in the documents incorporated by reference into this prospectus supplement.

Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

| Maxim Group LLC | Yorkville Securities |

<div align='center'>The date of this prospectus supplement is , 2025.

TABLE OF CONTENTS

Prospectus</div>

| ABOUT THIS PROSPECTUS SUPPLEMENT                      | S-1  |
| TRADEMARKS, TRADE NAMES AND SERVICE MARKS             | S-3  |
| MARKET, INDUSTRY AND OTHER DATA                       | S-4  |
| CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS | S-5  |
| PROSPECTUS SUMMARY                                    | S-7  |
| THE OFFERING                                          | S-11 |
| RISK FACTORS                                          | S-12 |
| USE OF PROCEEDS                                       | S-15 |
| DESCRIPTION OF COMMON SHARES                          | S-16 |
| DILUTION                                              | S-17 |
| PLAN OF DISTRIBUTION                                  | S-19 |
| LEGAL MATTERS                                         | S-21 |
| EXPERTS                                               | S-21 |
| WHERE YOU CAN FIND MORE INFORMATION                   | S-21 |
| INFORMATION INCORPORATED BY REFERENCE                 | S-21 |
| PART II  INFORMATION NOT REQUIRED IN PROSPECTUS       | II-1 |
| SIGNATURES                                            | II-9 |

<div align='center'>S-i

ABOUT THIS PROSPECTUS SUPPLEMENT</div>

This prospectus supplement relates to part of a registration statement on Form S-3 that we have filed with the SEC utilizing